Ono pharmaceutical stock. Ono Pharmaceutical's (TSE:4528) dividend yield is 4.
Ono pharmaceutical stock is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. 55% in one year. P/E ratio history for Ono Pharmaceutical from 2009 to 2023. Dashboard Portfolios Watchlist Community Discover Screener Ono Pharmaceutical Co. 11/02/2023. ADR stock information by Barron's. 5. 02 billion as of October 28, 2024. 24-06-10 A high-level overview of Ono Pharmaceutical Co. (OPHLY) stock quote, history, news and other vital information to help you with your stock trading and investing. 5 weeks ago - Equillium says Ono not acquiring itolizumab, stock craters 36% - Seeking Alpha ; Ono Pharmaceutical has been growing earnings at an average annual rate of 16%, while the Pharmaceuticals industry saw earnings growing at 4. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics. Osaka, Japan, October 10, 2024 - Ono Pharmaceutical Co. Stock quotes are provided by Factset, Ono Pharmaceutical Co Ltd (OPHLY) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 9. 8 months ago - Ono Pharmaceutical Co. Ltd (OPHLF) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. In depth view into OPHLY (Ono Pharmaceutical) stock including the latest price, news, dividend history, earnings information and financials. 2024 R & D U. (Cancellation of treasury stock pursuant to the provisions of Article 178 of the Companies Act) Osaka, Japan, March 29, 2024 - Ono Pharmaceutical Co. 5% and is now trading at $10. (4528. Start Free Trial . The beta is 0. Stocks. 09 ( -2. More information on the dividend of Ono Pharmaceutical and its contribution to the total return you can find in the dividend profile of Ono Pharmaceutical . The all-time high Ono Pharmaceutical stock closing price was 0. 50, with a volume of 11,572 shares trading hands. (Osaka, Japan; President: Toichi Takino, 'ONO') announced that for the fifth straight year it was selected for inclusion in the index components 'Dow Jones Sustainability Index (DJSI) World Index' and 'DJSI Asia Pacific Index' of the Dow Jones Sustainability Indices (DJSI), which are leading global environmental, social ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents. Market Cap Formula: Market Cap = Stock Price * Shares Outstanding. 7% lower at 1,619. Deciphera Pharmaceuticals Acquired by Ono Pharmaceutical for $2. ’s adoption of Kinaxis to help (Cancellation of treasury stock pursuant to the provisions of Article 178 of the Companies Act) Osaka, Japan, March 29, 2024 - Ono Pharmaceutical Co. 51 USD. (Daejeon, South Korea; CEO: Yong-Zu Kim; "LCB") for LCB97, a pre-clinical stage antibody-drug conjugate (ADC) ("this Agreement") aimed at being a first-in Ono Pharmaceutical Co. Ono Pharmaceutical shares last traded at $11. How do I buy shares of Ono Pharmaceutical? 小野薬品工業株式会社の「ir情報」ページです。「病気と苦痛に対する人間の闘いのために」という企業理念のもと、医療ニーズの高い疾患領域に挑戦し、独創的かつ画期的な医薬品の創製に向けて努力を積み重ねています。 Commitment to Conservation of the Global Environment; Information Disclosure Based on the TCFD Recommendation; Realization of a Decarbonized Society Equillium says Ono not acquiring itolizumab, stock craters 36%. (OPHLY) stock, including valuation metrics, financial numbers, share information and more. 3. The Company operates in one business segment. View today's Ono Pharmaceutical Ltd stock price and latest 4528 news and analysis. The words And Ono Pharmaceutical Co. P/E ratio for Ono Pharmaceutical (4528. 9 MB) 2Q Results：(Apr-Sep FY2020) Financial Results (561 KB) Presentation Materials. R＆D Innovative Pharmaceutical Products; Efforts Made for Improving Access to Healthcare; Respect for Human Rights; Expansion of Human Capital (Talent Development) Get a complete stock price history for OPHLF (Ono Pharmaceutical), starting from its first trading day. Since January 26, 2007, Ono Pharmaceutical's market cap has increased from 722. Shareholder Return Policy The Company considers the dividends are to be paid out in accordance with a progressive policy of maintaining or increasing the annual dividend each year, with a target payout ratio of 40%, taking into account the performance of each fiscal year and various indices. Search Commitment to Conservation of the Global Environment; Information Disclosure Based on the TCFD Recommendation; Realization of a Decarbonized Society Latest Ono Pharmaceutical Co Ltd (4528:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, ON4:MUN Munich Stock Exchange; ON4:STU Stuttgart Stock Exchange; 4528:DEU German Composite; ON4:FRA Frankfurt Stock Exchange; ON4:BER Berlin Stock Exchange; View today's Ono Pharmaceutical Co Ltd stock price and latest OPHLY news and analysis. Apr 30 Ono Pharmaceutical Co. 小野薬品工業株式会社の「ir情報」ページです。「病気と苦痛に対する人間の闘いのために」という企業理念のもと、医療ニーズの高い疾患領域に挑戦し、独創的かつ画期的な医薬品の創製に向けて努力を積み重ねています。 Ono Pharmaceutical Co. 82: 52 Week Low Discover real-time Ono Pharmaceutical Co. ono pharmaceutical co. (OPHLF) with a description, list of executives, contact details and other key facts. 6%. Osaka, Japan, June 20, 2024 - Ono Pharmaceutical Co. from BlackRock, Inc. (President and CEO, Gyo Sagara; “the Company”) today announced that, as resolved by documents instead of resolution by board meetings on July 25, 2023, it completed cancellation of own shares Deciphera Pharmaceuticals Acquired by Ono Pharmaceutical for $2. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced Ono Pharmaceutical Co. completed the acquisition of Deciphera Pharmaceuticals, Inc. 4528 | Complete Ono Pharmaceutical Co. (OPHLF) Q1 2024 Earnings Call Transcript - Seeking Alpha ; 8 months ago - ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals - PRNewsWire ; 8 months ago - Japan's Ono Pharma says $2. Monitor the latest movements within the Ono Pharmaceutical Ono Pharmaceutical Co. Hoerter, “Deciphera”) today announced that on April 29, The stock has a fifty day moving average of $10. (OPHLF) OTCMKTS · Delayed Price · Currency is USD . (NASDAQ: DCPH, Chief Executive Officer: Steven L. 03B: Telix Pharmaceuticals Limited: 4. 1%, and it has net margins of 19. Includes open, high, low, close and volume. 24-06-10 Commitment to Conservation of the Global Environment; Information Disclosure Based on the TCFD Recommendation; Realization of a Decarbonized Society 7 months ago - Ono Pharmaceutical Co. Joining the PSCI (Pharmaceutical Supply Chain Initiative) In September 2023, ONO joined PSCI (Pharmaceutical Supply Chain In ONO PHARMACEUTICAL CO. stock news by MarketWatch. 64B Concept Behind the New Commercial's Title "Rising to the challenges of Immuno-Oncology" For more than 300 years since its establishment in 1717, Ono has been taking on the challenge of researching and developing pharmaceuticals and generating innovative new drugs under the corporate philosophy "Dedicated to the Fight against Disease and Pain. Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s View Ono Pharmaceutical Co OPHLF investment & stock information. 0. 68 -0. Ltd ADR (OPHLY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Society : Sustainable Procurement. Create real-time notifications to follow any changes in the live stock price. Osaka, Japan - Ono Pharmaceutical Co. Latest Ono Pharmaceutical Co Ltd (4528:TYO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Ono Pharmaceutical Co Ltd (OPHLY) 3. Story Continues Find the latest Ono Pharmaceutical Co. Ono Pharmaceutical had revenue of 122. Equillium (EQ) stock cratered 36% after the company said it was pausing certain programs due to Ono Pharmaceutical failing to exercise an option to acquire its drug itolizumab. 4 bln Deciphera purchase 'first step' for global expansion - Reuters Stock analysis for Ono Pharmaceutical Co Ltd (4528:Tokyo) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 24-06-10 Deciphera Pharmaceuticals Acquired by Ono Pharmaceutical for $2. 1; 2; 3; 4; Stock price history for Ono Pharmaceutical (4528. 66B JPY in the quarter ending September 30, 2024, a decrease of -11. 4 bln Deciphera purchase 'first step' for global expansion 04-30 ONO PHARMACEUTICAL CO. (Headquarters: Osaka, Japan; President: Toichi Takino; 'Ono') today announced that Ono Pharma Taiwan Co. 39% ) USD | OTCM | Nov 20, 16:10 Summary of share price highs, lows and changes for Ono Pharmaceutical; Historical stock prices; Current Share Price: JP¥9. (Headquarters: Osaka, Japan; President: Toichi Takino; “the Company”) today announced that the payment procedures were completed on July 12, 2024 as follows for disposal of treasury shares as tenure-based restricted stock compensation and performance-linked restricted stock compensation resolved at the (Acquisition of own shares under the Articles of Incorporation pursuant to the provision of Paragraph 2, Article 165 of the Companies Act) Osaka, Japan, January 5, 2024 - Ono Pharmaceutical Co. Stock price history Social Contribution Activities; Efforts for the Advancement of Medicine and Pharmacy; Efforts for Supporting Health of Patients and Their Families The Ono Pharmaceutical stock reached its all-time high 9 years ago on 13/04/2016 at a stock price of 5,722. The transaction is expected to close in the third quarter of 2024. 4 billion buy-out offer from ONO Pharmaceuticals. 00. Research Ono Pharmaceutical's (TSE:4528) stock key valuation metrics while comparing it with its industry peers & market side by side. Distributed by Public, unedited and unaltered, on Stock quotes are provided by Factset, Morningstar and S&P Capital IQ View the real-time Ono Pharmaceutical Ltd (4528) stock price. In depth view into OPHLF (Ono Pharmaceutical) stock including the latest price, news, dividend history, earnings information and financials. Symbol. Today, the stock price is 71. Stock split history for Ono Pharmaceutical since . Company profile for Ono Pharmaceutical Co. , a Taiwanese subsidiary of Ono, received the additional approval of Opdivo (nivolumab) Intravenous Infusion ('Opdivo'), an anti-PD-1 antibody, in combination with cisplatin and gemcitabine, on . View the best growth stocks for 2025 here. Research Ono Pharmaceutical's (DB:ON4) stock price, latest news & stock analysis. 669367200565 JPY ($0. View the OPHLY premarket stock price ahead of the market session or assess the after hours quote. T) stock quote, history, news and other vital information to help you with your stock trading and investing. (TSE:4528) entered into a definitive merger agreement to acquire Deciphera Pharmaceuticals, Inc. (Headquarters: Osaka, Japan; President: Toichi Takino; 'Ono') today announced that it will begin airing its new commercial 'Rising to the challenges of Immuno-Oncology' in Japan from October 2, 2024. 2 billion. 5% per year. 840 Ono Pharmaceutical had revenue of 122. Lowest end of day price: 5. 2 months ago - Equillium says Ono not acquiring itolizumab, stock craters 36% - Seeking Alpha ; ONO PHARMACEUTICAL CO. ADR (OPHLY) stock price, news, historical charts, analyst ratings and financial information from WSJ. 24-06-10 Establishment of Ono Pharma Healthcare (1 MB) Script (1. Access comprehensive data, historical trends, and advanced technical analysis Since its establishment in 1717, ONO PHARMACEUTICAL has made progress for about 300 years--from the Edo, Meiji, The company listed its stock on the Osaka Stock Exchange Second Section in 1962 and the Tokyo Stock Exchange Second Section in next 1963. 4 bln Deciphera purchase 'first step' for global expansion - Reuters A high-level overview of Ono Pharmaceutical Co. 74B, an increase of 14. Stock Equities 4528 JP3197600004 Pharmaceuticals Market Closed - Japan Exchange. A vertical stack of three evenly spaced horizontal lines. 10653. (OPHLY) with a description, list of executives, contact details and other key facts. Full Definition. ONO Story. Stay Ono Pharmaceutical makes strategic business decision to allow itolizumab option to expire. Revenues have been growing at an average rate of 13. , (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, “ONO”) and Deciphera Pharmaceuticals, Inc. Ono Pharmaceutical's return on equity is 12. " ONO PHARMA UK LTD, London (UK) Lacon House, 84 Theobalds Road, London WC1X 8NL Tel: +44-20-7421-4920. Use the PitchBook Platform to explore the full profile. 60 a share in cash through a tender offer. Get the latest Ono Pharmaceutical Co. Dr. 48 USD) on 2016-04-13. (ONO), under which ONO will acquire all outstanding shares of Deciphera common stock for $25. 872efbc500aa5f6f52355. PO Osaka, Japan - Ono Pharmaceutical Co. Other stock markets. 705. Its market cap has decreased by -34. Its consolidated earnings in the half year ending in March 2018 were 16 billion Japanese yen. View daily, weekly or monthly format back to when Ono Pharmaceutical Co. Stock exchange listing : Tokyo Stock Exchange Real time Ono Pharmaceutical (OPHLY) stock price quote, stock graph, news & analysis. Ono Announces Status of Acquisition of Own Shares (Acquisition of own shares under the Articles of Incorporation pursuant to the provision of Paragraph 2, Article 165 of the Companies Act) Osaka, Japan, November 1, 2023 - Ono Pharmaceutical Co. 11. Get the latest Ono Pharmaceutical Co Ltd (ON4) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Company name : ONO PHARMACEUTICAL CO. ,ltd. (OPHLF) stock quote, history, news and other vital information to help you with your stock trading and investing. View the 4528 premarket stock price ahead of the market session or assess the after hours quote. 00 Shares of Ono Pharmaceutical Co. Solutions. , Deerfield Capital, L. 4B, common stock for $25. Osaka, Japan, July 12, 2024 - Ono Pharmaceutical Co. P. stock quotes reflect trades reported through Nasdaq only. OPHLF | Complete Ono Pharmaceutical Co. (4528) stock price, news, historical charts, analyst ratings and financial information from WSJ. 60 at the start of the year. 00: 52 Week High: JP¥2,777. , Redmile Group, LLC Brightstar Associates, LLC and others. Tasuku Honjo of Kyoto University, Historical daily share price chart and data for Ono Pharmaceutical since adjusted for splits and dividends. 63 and traded as high as $11. ; The Ono Pharmaceutical 52-week high stock price is 0. 60 per Share in Cash. , Ono has been listed in Tokyo Stock Exchange since 1963. Edit IPO & Stock Price Section. published this content on December 10, 2024, and is solely responsible for the information contained herein. 3% in the past month on a $2. 4 Billion 24-06-11: MT Ono Pharmaceutical Co. Analysts expect Ono Pharmaceutical will report earnings per share of ¥73. (Acquisition of own shares under the Articles of Incorporation pursuant to the provision of Paragraph 2, Article 165 of the Companies Act) Osaka, Japan, October 2, 2023 - Ono Pharmaceutical Co. (OPHLF) (Delayed Data from OTC) $10. [7] Nivolumab, the cancer drug based on the research of Prof. 6% this year versus the industry average of 0%. 3% annually. Find the latest Ono Pharmaceutical Co. (President and CEO, Gyo Sagara; “the Company”) today announced that, as resolved by documents instead of resolution by board meetings on July 25, 2023, it completed cancellation of own shares Company profile for Ono Pharmaceutical Co. Collapse. Concept Behind the New Commercial's Title 'Rising to the challenges of Immuno-Oncology' ONO PHARMACEUTICAL CO. Ono Pharmaceutical had 3,853 employees as of March 31, 2024. 60. P100 The ONO Group has identified 18 material issues as “priority management issues” that have incorporated into the medium- and long-term growth strategy Complete Ono Pharmaceutical Co. Equillium evaluating accelerating completion of Phase 3 EQUATOR study in aGVHD to Q1 2025 Deciphera Shareholders to Receive $25. looks attractive from a sales growth perspective as well. 51. CORPORATE REPORT 2023. Stock exchange listing : Tokyo Stock Exchange On January 31, Ono Pharmaceutical will report earnings from Q3. Find everything from its Valuation, Future Growth, Past Performance and more. Stock Price Statistics. 24-06-10 Information on stock, financials, earnings, subsidiaries, investors, and executives for ONO Pharmaceutical. Is Ono Pharmaceutical Co Ltd a Good Stock to Buy? Determining whether Ono Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. 10. 69%. Company Market Cap; Sandoz Group AG: 19. 00 on December 31, 1969. published this content on October 07, 2024 and is solely responsible for the information contained herein. 06-10: CI Japan's Ono Pharma says $2. OTC Markets. 63 Find the latest Ono Pharmaceutical Co. (TYO: 4528) stock price quote with financials, statistics, dividends, charts and more. Discover historical prices for 4528. dI34757pBRwbX_HeF0buvlddCLVfFeEsavDL_bQ5ssA. Ono Pharmaceutical Co Ltd (OPHLF) Ono Pharmaceutical Co Ltd is a drug manufacturer with a focus on drug discovery in Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 (IFRS) May 11, 2021 Company name : ONO PHARMACEUTICAL CO. ONO Pharmaceutical Co. Get the latest Ono Pharmaceutical Co Ltd (4528) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2386020338643 JPY ($0. The latest closing stock price for Ono Pharmaceutical as of December 31, 1969 is 0. The company's sales are expected to grow 11. 23. (President and CEO, Gyo Sagara; “the Company”) today announced that it has acquired its own shares pursuant to the provision of Article 156 of the Companies Deciphera Pharmaceuticals Acquired by Ono Pharmaceutical for $2. Please see the "Historical Prices" tab for adjusted price values. 00 JPY. The number of employees increased by 92 or 2. ’s adoption of Kinaxis to help orchestrate full visibility and transparency across its global supply ONO’s 300-Year History; Videos and Advertisements Top "Rising to the challenges of Immuno-Oncology" CLOSE. Search Crunchbase. Home. (Headquarters: Osaka, Japan; President: Toichi Takino; “Ono”) today announced that it was continuously selected as a constituent stock of the following ESG (Environmental, Social and Governance) investment indexes adopted by the Government Pension Investment Fund (GPIF), and ESG investment Ono Pharmaceutical Co Ltd stock price live, this page displays OTC OPHLY stock exchange data. (Headquarters: Osaka, Japan; President: Toichi Takino; “the Company”) today announced that it resolved at the meeting of the Board of Directors held today to dispose of its treasury shares as tenure-based restricted stock compensation and performance-linked restricted stock compensation (hereinafter referred to Kinaxis provides end-to-end supply chain orchestration platform to support Ono Pharmaceutical’s further global growthOTTAWA, Ontario--(BUSINESS WIRE)-- Kinaxis ® Inc. The company was founded by Ichibei 4528 | Complete Ono Pharmaceutical Co. Chrome Extension. 00% year-over-year. Equillium says Ono not acquiring itolizumab, stock craters 36%. 00 (0. 🚀 Enjoy a 7-Day Free Trial Thru Nov 15, 2024! Sign Up Ono Pharmaceutical Co. T) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Find the latest Ono Pharmaceutical Co. Ltd. Cambridge (USA) ONO PHARMA USA, INC. 18: 52-Week Price Change -36. At the end of 2022 the company had a P/E ratio of 13. Commitment to Conservation of the Global Environment; Information Disclosure Based on the TCFD Recommendation; Realization of a Decarbonized Society Ono Pharmaceutical's stock was trading at $9. 56%. Since then, OPHLF shares have increased by 9. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Related Stocks. 50. 89%. Distributed by Public, unedited and unaltered, on December 10, 2024 at 04:02:02. Assess historical data, charts, technical analysis and contribute in the forum. 00%) We are aiming for sustainable growth. 30B, down -1. 45% compared to the previous year. 91%. , system Corporate Governance Report Please refer to the “Corporate Governance Report” below for details on our corporate governance situation. Financial Results (715 KB) Development Pipeline Progress Status (1. (NasdaqGS:DCPH) for $2. to Report Fiscal Year 2024 Results on May 09, 2024 The latest Ono stock prices, stock quotes, news, and history to help you invest and trade smarter. S. Food and Drug Administration sBLA Acceptance for First-Line Treatment of Unresectable Hepatocellular Carcinoma 23/08: PU Ono Pharmaceutical : Selected for ESG Investment Indexes Adopted by GPIF 20/08 Ono Pharmaceutical had 3,853 employees as of March 31, 2024. Log In Sign Up. The latest Ono Pharmaceutical stock prices, stock quotes, news, and OPHLF history to help you invest and trade smarter. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ The latest ONO PHARMACEUTICAL stock prices, stock quotes, news, and OPHLY history to help you invest and trade smarter. (OPHLF) stock. 78%. 04288 USD) on 2002-11-19. R＆D Innovative Pharmaceutical Products; Efforts Made for Improving Access to Healthcare; Respect for Human Rights; Expansion of Human Capital (Talent Development) Ono Pharmaceutical Ltd stock price live, this page displays TYO 4528 stock exchange data. (Headquarters: Osaka, Japan; President: Toichi Takino; "Ono") today announced that it has entered into a license agreement with LigaChem Biosciences, Inc. Get the latest Ono Pharmaceutical Co OPHLF detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Watchlist. Monitor the latest movements within the Ono The acquisition of Deciphera by ONO Pharmaceutical is a transformative event for Deciphera's shareholders, offering a 74. Stock Analysis Pro. (President and CEO, Gyo Sagara; “the Company”) today announced that it has acquired its own shares pursuant to the provision of Article 156 of the Companies Ono Pharmaceutical Co. ONO Earned Top Score in the Pharmaceutical Sector of the Dow Jones Sustainability Index Selected for the World Index and Asia Pacific Index for Five Straight Years; Dec. 7% premium over the closing price on April 26, 2024. This brings the company's revenue in the last twelve months to 484. Stock Symbol TYO:4528 ; IPO Date Jun 1, 1963; Stock chart by . and CEO(President, Gyo Osaka, Japan, August 20, 2024 – Ono Pharmaceutical, Co. Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2022 (IFRS) January 31, 2022 . Ono Pharmaceutical has a market cap or net worth of $6. This selection marks the second time in four years since FY2020. 01:30:00 2025-01 Name of shareholder Number of shares held (Thousands of shares) Shareholding percentage Summary of share price highs, lows and changes for Ono Pharmaceutical; Historical stock prices; Current Share Price: JP¥1,635. , LTD. The stock has a fifty day moving average of $10. Find the latest Ono Pharmaceutical Co. The stock price has decreased by -39. 11,099 The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. General Affairs Mail：[email protected] Inquiry regarding compliance Click here for the “ONO Group Compliance Hotline” *It may take time to respond to inquiries received during our holidays. , ono pharmaceutical co. . Beta (5Y) 0. FDA Approves Pfizer’s BRAFTOVI® Combination Regimen as First-Line Treatment of BRAF V600E-Mutant Metastatic Colorectal Cancer; Get the latest Ono Pharmaceutical Co Ltd (OPHLF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (Chairman and CEO: Gyo Sagara, “Ono”) today announced that it has successfully completed the tender offer, previously announced on April 30, 2024 to acquire all outstanding shares of common stock of a US biopharmaceutical company, Deciphera Pharmaceuticals, Find the latest Ono Pharmaceutical Co. According to Ono Pharmaceutical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 6. Stock analysis for Ono Pharmaceutical Co Ltd (OPHLY:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. T) Highest end of day price: 52. Skip to main content. (TYO: 4528) with a description, list of executives, contact details and other key facts. 24-06-10 Deciphera stock rocketed to a three-year high Monday after Ono Pharmaceutical agreed to buy it for $2. ONO’s 300-Year History; Videos and Advertisements Top "Rising to the challenges of Immuno-Oncology" CLOSE. Investor's Business Daily • 8 months ago OPHLY Osaka, Japan and Waltham, Massachusetts, June 11, 2024 – Ono Pharmaceutical, Co. Ono Pharmaceutical Co. View the latest Ono Pharmaceutical Co. This deal highlights ONO's strategy to expand its oncology portfolio and establish a global specialty pharma identity. Prices shown are actual historical values and are not adjusted for either splits or dividends. ONO PHARMACEUTICAL CO. T stock on Yahoo Finance. T) P/E ratio as of January 2025 (TTM): 6. Stay ahead with Nasdaq. View real-time stock prices and stock quotes for a full financial overview. 96%: 50-Day Moving Average : 4. Change (1Y) 92. 06/16/2023. 3 Ono Pharmaceutical Co. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. Get Ono Pharmaceutical Co Ltd (4528. 06. Ono Pharmaceutical's (TSE:4528) dividend yield is 4. Ono Pharmaceutical : Bristol Myers Squibb Receives U. Employees 3,853. Detailed statistics for Ono Pharmaceutical Co. View real-time OPHLY stock price and news, along with industry-best analysis. Dividend payments have increased over the last 10 years and are covered by earnings with a payout ratio of 39. Detailed balance sheet for Ono Pharmaceutical (TYO: 4528), including cash, debt, assets, liabilities, and book value. 20B to 829. 60: 52 Week High: JP¥16. 06% in the last 52 weeks. 00, which is NAN% above the current Osaka, Japan and Waltham, Massachusetts, April 30, 2024 – ONO Pharmaceutical, Co. (Osaka, Japan; President and CEO: Gyo Sagara, "Ono") announced that it has been selected as a "2024 Health & Productivity Stock" jointly managed by the Ministry of Economy, Trade and Industry (METI) and the Tokyo Stock Exchange (TSE). , Ltd. 14 ONO Pharmaceutical Co. (OPHLY) OTCMKTS · Delayed Price · Currency is USD . engages in the production, purchase, Real-time last sale data for U. ONO Pharmaceutical is registered under the ticker TYO:4528 . Videos and Advertisements. Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s Pipeline and Ltd. " Discover historical prices for OPHLY stock on Yahoo Finance. (OTCMKTS:OPHLF – Get Free Report) passed above its fifty day moving average during trading on Monday . 4 billion. (OPHLY) stock. Follow Ono Pharmaceutical stock price in real-time here. Detailed statistics for Ono so Ono Pharmaceutical's price volatility has been lower than the market average. 60 per share in cash through a tender offer followed by a merger of Stay updated with the latest Ono Pharmaceutical Ltd stock price movements on our real-time chart. Chapter 3 "One of the most challenging tasks for human beings is In recognition of such activities, Ono Pharmaceutical has been recognized for six consecutive years as a “Certified Health & Productivity Management Outstanding Organization (White 500),” and we have also been selected as a "2024 Health & Productivity Stock. Commitment to Conservation of the Global Environment; Information Disclosure Based on the TCFD Recommendation; Realization of a Decarbonized Society Company profile for Ono Pharmaceutical Co. R＆D Innovative Pharmaceutical Products; Efforts Made for Improving Access to Healthcare; Respect for Human Rights; Expansion of Human Capital (Talent Development) OTTAWA, Ontario, October 07, 2024--Kinaxis® Inc. That is a compound annual growth rate of 0. Our Vision Be Passionate Challengers Stock Information 101 103 105 106 110. stock was issued. 17, so Ono Pharmaceutical's price volatility has been lower than the market average. , Cambridge (USA) Riverfront Office Park, 1 Main Street, Suite 1050, Deciphera (DCPH) soars 74. 4 MB) Trend of Opdivo (1. In our long-term vision, we aim to become a Global Specialty Pharma that invests 200 billion yen per year in R&D, which is on par with Japan’s largest pharmaceutical companies, and that is providing a Japanese pharmaceutical company ONO Pharmaceutical has announced its acquisition of Deciphera Pharmaceuticals for $2.